Satellite Session | BENEFIT Kids

Thursday, November 16, 12:30pm - 2:00pm (EST)

Time shown in-04:00 America, New York

The Unitaid-funded BENEFIT Kids project addresses critical research gaps to improve care for children affected by multidrug-resistant TB (MDR-TB). The program aims to reduce paediatric morbidity and mortality through better access to improved prevention and treatment strategies. BENEFIT Kids includes clinical trials incorporating efficacy, safety, pharmacokinetics, acceptability, and costing, with community involvement being central. The session aims to highlight key project findings impacting policy and practice. Raj Taneja, Vice President, Pharmaceutical Product Development at TB Alliance will provide an overview of ChilPref, a program about how children’s taste preferences informed the development of moxifloxacin and linezolid pediatric formulations.

Please see the online program for more information.

Add to Calendar 2023/11/16 18:30:00 2023/11/16 20:00:00 Europe/Paris Satellite Session | BENEFIT Kids The Unitaid-funded BENEFIT Kids project addresses critical research gaps to improve care for children affected by multidrug-resistant TB (MDR-TB). The program aims to reduce paediatric morbidity and mortality through better access to improved prevention and treatment strategies. BENEFIT Kids includes clinical trials incorporating efficacy, safety, pharmacokinetics, acceptability, and costing, with community involvement being central. The session aims to highlight key project findings impacting policy and practice. Raj Taneja, Vice President, Pharmaceutical Product Development at TB Alliance will provide an overview of ChilPref, a program about how children’s taste preferences informed the development of moxifloxacin and linezolid pediatric formulations.

Please see the online program for more information. 242A false MM/DD/YYYY 30 OPAQUE ambQfBYOGzRZxDTimmgh72967

242A

TB Alliance at the Union Conference

Link: